Martin Aryee, Ph.D.
Martin Aryee is an institute member of the Broad Institute of MIT and Harvard, an associate professor in the Department of Data Sciences at Dana-Farber Cancer Institute (DFCI), and director of hematologic malignancies, biostatistics and computational biology at DFCI. He holds a secondary appointment as an assistant professor in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health, where he teaches an introductory course in statistical genetics. Aryee is also a recipient of the Merkin Institute Fellowship at the Broad.
The Aryee lab develops statistical analysis methods for studying the genetic and epigenetic basis of cancer and other diseases. Most of their work has focused on improving our understanding of how aberrations in the physical and chemical structure of DNA within the nucleus are linked to cancer and other common diseases. Projects range from basic biology, to probing how DNA misfolds in cancer cells, to clinical applications aiming to develop blood tests for early detection of cancer. His lab also develops tools that aim to enable the safe translation of gene editing techniques such as CRISPR into human therapeutics.
Aryee earned an M.Eng. in electronic engineering at Imperial College London, and an M.Sc. in neuroscience at King’s College London. He earned his Ph.D. in biostatistics from the Harvard T.H. Chan School of Public Health.